{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:21:12Z","timestamp":1759940472640,"version":"3.41.2"},"reference-count":23,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:p>Secondary hyperparathyroidism (SHPT) is a rare complication of furosemide therapy that can occur in patients treated with the loop diuretic for a long period of time. We report a 6-month-old 28-weeks premature infant treated chronically with furosemide for his bronchopulmonary dysplasia, who developed hypocalcemia and severe SHPT, adversely affecting his bones. Discontinuation of the loop diuretic and the addition of supplemental calcium and calcitriol only partially reversed the SHPT, bringing serum parathyroid hormone level down from 553 to 238 pg\/mL. After introduction of the calcimimetic Cinacalcet, we observed a sustained normalization of parathyroid hormone concentration at 27 to 63 pg\/mL and, with that correction, of all biochemical abnormalities and healing of the bone disease. No adverse effects were noted. We conclude that in cases of SHPT due to furosemide in which traditional treatment fails, there may be room to consider the addition of a calcimimetic agent.<\/jats:p>","DOI":"10.1542\/peds.2016-3789","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T08:30:19Z","timestamp":1512030619000},"source":"Crossref","is-referenced-by-count":8,"title":["Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet"],"prefix":"10.1542","volume":"140","author":[{"given":"Tarak","family":"Srivastava","sequence":"first","affiliation":[{"name":"Sections of Nephrology, Bone and Mineral Disorder Clinic, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahryar","family":"Jafri","sequence":"additional","affiliation":[{"name":"Sections of Nephrology, Bone and Mineral Disorder Clinic, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Truog","sequence":"additional","affiliation":[{"name":"Neonatology, The Children\u2019s Mercy Hospitals and Clinics, University of Missouri at Kansas City, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Sebestyen VanSickle","sequence":"additional","affiliation":[{"name":"Sections of Nephrology, Bone and Mineral Disorder Clinic, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston M.","family":"Manimtim","sequence":"additional","affiliation":[{"name":"Neonatology, The Children\u2019s Mercy Hospitals and Clinics, University of Missouri at Kansas City, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri S.","family":"Alon","sequence":"additional","affiliation":[{"name":"Sections of Nephrology, Bone and Mineral Disorder Clinic, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"issue":"3","key":"2021121022430335700_B1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.70.3.360","article-title":"Renal calcifications: a complication of long-term furosemide therapy in preterm infants.","volume":"70","author":"Hufnagle","year":"1982","journal-title":"Pediatrics"},{"issue":"8","key":"2021121022430335700_B2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s004310051173","article-title":"Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up.","volume":"158","author":"Saarela","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"12","key":"2021121022430335700_B3","first-page":"1157","article-title":"Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy.","volume":"137","author":"Venkataraman","year":"1983","journal-title":"Am J Dis Child"},{"issue":"1","key":"2021121022430335700_B4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamainternmed.2014.5857","article-title":"Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function.","volume":"175","author":"Corapi","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2021121022430335700_B5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI107156","article-title":"Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.","volume":"52","author":"Coe","year":"1973","journal-title":"J Clin Invest"},{"issue":"4","key":"2021121022430335700_B6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000183610","article-title":"The effects of oral furosemide on the response of urinary excretion of cyclic adenosine monophosphate and phosphate to parathyroid extract in normal subjects.","volume":"41","author":"Fujita","year":"1985","journal-title":"Nephron"},{"issue":"4","key":"2021121022430335700_B7","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/ndt\/gfr026","article-title":"Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.","volume":"26","author":"Isakova","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2021121022430335700_B8","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00424-015-1714-4","article-title":"Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.","volume":"467","author":"Muller","year":"2015","journal-title":"Pflugers Arch"},{"issue":"1","key":"2021121022430335700_B9","first-page":"482","article-title":"Diseases and clinical applications of the calcium sensing receptor.","volume":"5","author":"Alon","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"issue":"5","key":"2021121022430335700_B10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00467-015-3271-7","article-title":"Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b.","volume":"31","author":"Srivastava","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2021121022430335700_B11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jbmr.1838","article-title":"Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets.","volume":"28","author":"Srivastava","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2021121022430335700_B12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00467-007-0742-5","article-title":"Cinacalcet is efficacious in pediatric dialysis patients.","volume":"23","author":"Silverstein","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"2021121022430335700_B13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00467-010-1547-5","article-title":"Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia.","volume":"25","author":"Alon","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2021121022430335700_B14","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3476(83)80253-4","article-title":"Pulmonary effects of furosemide in preterm infants with lung disease.","volume":"102","author":"Najak","year":"1983","journal-title":"J Pediatr"},{"issue":"6","key":"2021121022430335700_B15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","article-title":"Update in diuretic therapy: clinical pharmacology.","volume":"31","author":"Brater","year":"2011","journal-title":"Semin Nephrol"},{"issue":"1","key":"2021121022430335700_B16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/JBMR.051003","article-title":"Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide.","volume":"21","author":"Rejnmark","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2021121022430335700_B17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","article-title":"Fracture risk in patients treated with loop diuretics.","volume":"259","author":"Rejnmark","year":"2006","journal-title":"J Intern Med"},{"issue":"2","key":"2021121022430335700_B18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archinternmed.2008.526","article-title":"Loop diuretic use and fracture in postmenopausal women: findings from the Women\u2019s Health Initiative.","volume":"169","author":"Carbone","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"2021121022430335700_B19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000446449","article-title":"Furosemide increases the risk of hyperparathyroidism in chronic kidney disease.","volume":"43","author":"Vasco","year":"2016","journal-title":"Am J Nephrol"},{"issue":"4","key":"2021121022430335700_B20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2265.1996.701521.x","article-title":"Risk factors for secondary hyperparathyroidism in a nursing home population.","volume":"44","author":"Stein","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2021121022430335700_B21","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2015-1619","article-title":"Hypertension, antihypertensive medications, and risk of incident primary hyperparathyroidism.","volume":"100","author":"Vaidya","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121022430335700_B22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cen.13046","article-title":"The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism.","volume":"85","author":"Riss","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2021121022430335700_B23","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1523-1755.2004.00564.x","article-title":"Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat.","volume":"65","author":"Pattaragarn","year":"2004","journal-title":"Kidney Int"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-3789\/911662\/peds_20163789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-3789\/911662\/peds_20163789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T07:43:50Z","timestamp":1639208630000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/140\/6\/e20163789\/38154\/Successful-Reversal-of-Furosemide-Induced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-3789","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2017,12,1]]},"article-number":"e20163789"}}